Trovafloxacin mesylate Size:Contact [email protected] for quotation orally bioavailable BTK inhibitor and

orally bioavailable BTK inhibitor and shows inhibitory effect toward BMX nonreceptor tyrosine kinase and TEC

AZD9272 completely reverses the glutamate-stimulated (EC80

InChiKey: XACCKEPNGBUXQW-VEIFNGETSA-N

InChi: InChI=1S/C15H26N2O5/c1-8(2)5-6-16-13(18)10(7-9(3)4)17-14(19)11-12(22-11)15(20)21/h8-12H

Intradermal injection of compound 48/80 (50 μg in 50 μL saline) resulted in a clear wheal and flare reaction over the 60 min observation period

Trovafloxacin mesylate Size:Contact [email protected] for quotation orally bioavailable BTK inhibitor andTrovafloxacin mesylate is a broad spectrum quinolone antibiotic with potent activity against Gram positive, Gram negative and anaerobic organisms. Trovafloxacin mesylate blocks the DNA gyrase and topoisomerase IV activity. Trovafloxacin mesylate is also a potent, selective and orally active pannexin 1 channel (PANX1) inhibitor with an IC50 of 4 M for PANX1 inward current. Trovafloxacin mesylate does not inhibit connexin 43 gap junction or PANX2.